News
Baird Maintains Neutral on Amylyx Pharma, Lowers Price Target to $3
11 Apr 24
News, Price Target, Analyst Ratings
HC Wainwright & Co. Reiterates Buy on Amylyx Pharma, Maintains $8 Price Target
11 Apr 24
News, Price Target, Reiteration, Analyst Ratings
Amylyx Pharmaceuticals' Investigational Drug Shows Improved Pancreatic Function In Patients With Inherited Disorder
10 Apr 24
Movers
Amylyx Pharmaceuticals Announces Interim Data From Phase 2 HELIOS Clinical Trial Of AMX0035 In Adults With Wolfram Syndrome
10 Apr 24
Biotech, News, General
Amylyx Pharmaceuticals To Host Virtual Webcast To Discuss Interim Data From Phase 2 HELIOS Study Of AMX0035 In Wolfram Syndrome On April 10, 2024
8 Apr 24
Biotech, News, General
Unveiling 6 Analyst Insights On Amylyx Pharma
8 Apr 24
Analyst Ratings
HC Wainwright & Co. Maintains Buy on Amylyx Pharma, Maintains $8 Price Target
8 Apr 24
News, Price Target, Analyst Ratings
Amylyx Pharmaceuticals Announces Formal Intention to Remove Relyvrio/Albrioza From The Market
4 Apr 24
Biotech, News, Health Care, General
CNS Disorder-Focused Seelos Therapeutics Plunges To 52-Week Low - Here's Why
19 Mar 24
Biotech, News, Health Care, Movers, General
HC Wainwright & Co. Maintains Buy on Amylyx Pharma, Lowers Price Target to $8
12 Mar 24
News, Price Target, Analyst Ratings
Goldman Sachs Downgrades Amylyx Pharma to Neutral, Lowers Price Target to $4
11 Mar 24
News, Downgrades, Price Target, Analyst Ratings
Leerink Partners Downgrades Amylyx Pharma to Market Perform
11 Mar 24
News, Downgrades, Analyst Ratings
Baird Downgrades Amylyx Pharma to Neutral, Lowers Price Target to $4
11 Mar 24
News, Downgrades, Price Target, Analyst Ratings
Dow Gains Over 100 Points; AerSale Shares Plunge After Q4 Results
8 Mar 24
Earnings, News, Penny Stocks, Eurozone, Commodities, Small Cap, Global, Intraday Update, Markets, Trading Ideas
Stocks Fall As Chipmakers Retreat From Highs, Bitcoin Pulls Back After $70,000, Gold Rises To $2,200: What's Driving Markets Friday?
8 Mar 24
Analyst Color, Earnings, Earnings Misses, Equities, Large Cap, Mid Cap, Broad U.S. Equity ETFs, Small Cap, Econ #s, Top Stories, Economics, Federal Reserve, Intraday Update, Analyst Ratings, Tech, ETFs
Evercore ISI Group Downgrades Amylyx Pharma to In-Line
8 Mar 24
News, Downgrades, Analyst Ratings
Why Marvell Technology Shares Are Trading Lower By 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session
8 Mar 24
News, Penny Stocks, Small Cap, Intraday Update, Markets, Movers, Trading Ideas
Crude Oil Falls Over 1%; Willdan Group Shares Spike Higher
8 Mar 24
Earnings, News, Penny Stocks, Eurozone, Commodities, Small Cap, Global, Intraday Update, Markets, Trading Ideas
9 Health Care Stocks Whale Activity In Today's Session
8 Mar 24
Options
12 Health Care Stocks Moving In Friday's Intraday Session
8 Mar 24
Movers
Press releases
Investigation Alert Amylyx, Hut 8, Xponential Fitness, and iRhythm Technologies: Submit Your Information Now to Johnson Fistel, LLP
15 Apr 24
News, Legal, Press Releases
DEADLINE ALERT for XPOF, LUXH, and AMLX: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders
9 Apr 24
News, Legal, Press Releases
The Gross Law Firm Notifies Amylyx Pharmaceuticals, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - AMLX
9 Apr 24
Press Releases
Amylyx Pharmaceuticals, Inc. investors: Please contact the Portnoy Law Firm to recover your losses; April 9, 2024 deadline
8 Apr 24
News, Legal, Press Releases
The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Amylyx Pharmaceuticals, Inc. (AMLX)
8 Apr 24
Penny Stocks, Press Releases
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Amylyx Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadlines – AMLX
8 Apr 24
News, Legal, Press Releases
AMLX DEADLINE TOMORROW: ROSEN, LEADING INVESTOR COUNSEL, Encourages Amylyx Pharmaceuticals, Inc. Investors to Secure Counsel Before Important April 9 Deadline in Securities Class Action – AMLX
8 Apr 24
News, Legal, Press Releases
Amylyx Pharmaceuticals to Host Virtual Webcast to Discuss Interim Data from Phase 2 HELIOS Study of AMX0035 in Wolfram Syndrome on April 10, 2024
8 Apr 24
Press Releases
Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Amylyx Pharmaceuticals, Inc.(AMLX) Shareholders
8 Apr 24
Press Releases
AMLX 2-DAY DEADLINE ALERT: Hagens Berman, National Trial Attorneys, Encourages Amylyx Pharmaceuticals (AMLX) Investors with Substantial Losses to Contact Firm Before Apr. 9th Deadline in Securities Fraud Class Action
7 Apr 24
News, Legal, Press Releases
AMLX INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Amylyx Pharmaceuticals, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
7 Apr 24
News, Legal, Press Releases
AMYLYX PHARMACEUTICALS 96 HOUR DEADLINE ALERT: Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors With Losses in Excess of $100,000 of Deadline in Class Action Lawsuit Against Amylyx Pharmaceuticals, Inc. - AMLX
5 Apr 24
Press Releases
AMLX Investors Have Opportunity to Lead Amylyx Pharmaceuticals, Inc. Securities Fraud Lawsuit
5 Apr 24
Penny Stocks, Press Releases
Amylyx Pharmaceuticals, Inc. Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm for More Information - AMLX
5 Apr 24
Press Releases
Amylyx Pharmaceuticals, Inc. Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm for More Information - AMLX
5 Apr 24
Press Releases
AMLX FINAL DEADLINE: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Amylyx Pharmaceuticals, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important April 9 Deadline in Securities Class Action - AMLX
4 Apr 24
Press Releases
AMLX FINAL DEADLINE: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Amylyx Pharmaceuticals, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important April 9 Deadline in Securities Class Action - AMLX
4 Apr 24
Press Releases
AMLX DEADLINE ALERT: ROSEN, LEADING INVESTOR COUNSEL, Encourages Amylyx Pharmaceuticals, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important April 9 Deadline in Securities Class Action – AMLX
4 Apr 24
Press Releases
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Amylyx Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadlines - AMLX
4 Apr 24
Press Releases
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Amylyx Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadlines - AMLX
4 Apr 24
Press Releases